Switching from scanned to real-time CGM for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests whether switching from a FreeStyle Libre 2 (which you scan to check sugar) to a Dexcom G7 (which sends sugar readings automatically to your phone) can improve blood sugar control in adults with type 2 diabetes who use insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have type 2 diabetes for at least 1 year
- You've been using insulin for at least 6 months
- You currently use a FreeStyle Libre 2 (scanned) CGM and want to switch to a Dexcom G7 (real-time) CGM
- Your most recent HbA1c (blood sugar average over 3 months) is 7.5% or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
This trial compares two types of continuous glucose monitors to see which works better for people with type 2 diabetes who use insulin. You will wear a sensor that tracks your blood sugar levels continuously or at set times, and the study will help find the best way to manage your diabetes.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This study tests whether using a continuous glucose monitor (FreeStyle Libre 2) along with smart insulin pens or caps helps people with type 1 diabetes better manage their blood sugar on their own. If you already use this device and take multiple daily insulin injections, you may be eligible.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.